Correlation Between Eventide Healthcare and Dreyfus Research

Can any of the company-specific risk be diversified away by investing in both Eventide Healthcare and Dreyfus Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eventide Healthcare and Dreyfus Research into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eventide Healthcare Life and Dreyfus Research Growth, you can compare the effects of market volatilities on Eventide Healthcare and Dreyfus Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eventide Healthcare with a short position of Dreyfus Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eventide Healthcare and Dreyfus Research.

Diversification Opportunities for Eventide Healthcare and Dreyfus Research

-0.09

Correlation Coefficient

Eventide Healthcare  Dreyfus Research

Good diversification

The 3 months correlation between Eventide and Dreyfus is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Eventide Healthcare Life and Dreyfus Research Growth in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dreyfus Research Growth and Eventide Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eventide Healthcare Life are associated (or correlated) with Dreyfus Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dreyfus Research Growth has no effect on the direction of Eventide Healthcare i.e., Eventide Healthcare and Dreyfus Research go up and down completely randomly.

Pair Corralation between Eventide Healthcare and Dreyfus Research

Assuming the 90 days horizon Eventide Healthcare is expected to generate 21.17 times less return on investment than Dreyfus Research. In addition to that, Eventide Healthcare is 1.32 times more volatile than Dreyfus Research Growth. It trades about 0.0 of its total potential returns per unit of risk. Dreyfus Research Growth is currently generating about 0.09 per unit of volatility. If you would invest  1,292  in Dreyfus Research Growth on October 7, 2024 and sell it today you would earn a total of  779.00  from holding Dreyfus Research Growth or generate 60.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Eventide Healthcare Life  vs.  Dreyfus Research Growth

Eventide Healthcare Life

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eventide Healthcare Life has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong technical indicators, Eventide Healthcare is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Dreyfus Research Growth

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Dreyfus Research Growth are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Dreyfus Research may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Eventide Healthcare and Dreyfus Research

The main advantage of trading using opposite Eventide Healthcare and Dreyfus Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eventide Healthcare position performs unexpectedly, Dreyfus Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dreyfus Research will offset losses from the drop in Dreyfus Research's long position.

The idea behind Eventide Healthcare Life and Dreyfus Research Growth pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.